Mukka Proteins Q1 Results: Net profit jumps 1073% YoY to ₹186.34 crore
Mukka Proteins posted a consolidated net profit of ₹186.34 million for Q1FY27, up 1073% YoY, driven by an 188% surge in revenue to ₹4,896.54 million. Export markets contributed significantly to the top-line growth. The Board approved a ₹64.93 million investment in Swachha Eco Solutions Private Limited and cancelled a planned ₹750 million NCD issuance. Key management re-appointments were also ratified.

*this image is generated using AI for illustrative purposes only.
The Board of Directors of Mukka Proteins Limited approved the unaudited consolidated financial results for the quarter ended June 30, 2026, on August 12, 2026. The company reported a consolidated net profit after tax of ₹186.34 million, compared to ₹15.89 million in the corresponding quarter of the previous fiscal year. Total comprehensive income stood at ₹196.55 million.
Consolidated revenue from operations reached ₹4,748.04 million, marking a significant increase from ₹1,648.81 million in the quarter ended June 30, 2025. Including other operating income of ₹148.50 million, total revenue from operations amounted to ₹4,896.54 million. Standalone net profit for the quarter was ₹194.07 million, up from ₹11.35 million year-on-year, with standalone revenue from operations at ₹3,927.05 million.
Financial Performance
The company’s cost of materials consumed was ₹3,919.82 million in the consolidated results. Employee benefit expenses rose to ₹163.35 million from ₹78.89 million in the prior year quarter. Finance costs increased to ₹164.52 million from ₹110.41 million. Depreciation and amortisation expenses were recorded at ₹47.97 million.
| Metric | Q1 FY27 (Consolidated) | Q1 FY26 (Consolidated) |
|---|---|---|
| Revenue from Operations | ₹4,748.04 million | ₹1,648.81 million |
| Total Revenue | ₹4,896.54 million | ₹1,707.74 million |
| Profit After Tax | ₹186.34 million | ₹15.89 million |
| Earnings Per Share (Basic) | ₹0.63 | ₹0.05 |
Geographically, revenue outside India contributed ₹4,140.68 million to the total, while domestic revenue within India accounted for ₹607.36 million. In the standalone segment, international revenue was ₹3,526.55 million against domestic revenue of ₹400.51 million.
Strategic Investments and Capital Actions
The Board approved an investment in Swachha Eco Solutions Private Limited (SESPL), involving a capital contribution of ₹64.925 million (₹64,92,500). This transaction secures a 25.98% stake in SESPL, making it an associate of Mukka Proteins. The investment aligns with the company’s strategy to expand its waste management segment. SESPL, incorporated in September 2017, operates in the collection, treatment, and disposal of waste. Its turnover for FY26 was ₹1.77 million, with a net loss of ₹7.50 million.
Additionally, the Board cancelled and withdrew the proposed issuance of Senior, Secured, Rated, Listed, Redeemable, Taxable, Transferable, INR Denominated Non-Convertible Debentures aggregating up to ₹750 million on a private placement basis.
Board Appointments
The meeting included the re-appointment of several key executives and directors for five-year terms commencing January 2027, subject to shareholder approval at the 16th Annual General Meeting scheduled for September 10, 2026:
- Mr. Kalandan Mohammed Haris as Managing Director and CEO
- Mr. Kalandan Mohammed Althaf as Whole-Time Director and CFO
- Mr. Kalandan Mohammad Arif as Whole-Time Director and COO
- Mr. Karkala Shankar Balachandra Rao, Mr. Hamad Bava, and Mr. Narendra Surendra Kamath as Non-Executive Independent Directors
What the Numbers Show
The divergence between standalone and consolidated profits highlights the impact of joint ventures and associates. While standalone profit before tax was ₹274.99 million, the share of net loss from associates and joint ventures reduced the consolidated profit before tax to ₹273.74 million. This indicates that despite strong core operational performance, investments in joint ventures continue to exert downward pressure on consolidated earnings.
Historical Stock Returns for Mukka Proteins
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +1.68% | +5.36% | +0.75% | -1.63% | -10.48% | -42.77% |
How will the strategic acquisition of a 25.98% stake in Swachha Eco Solutions impact Mukka Proteins' long-term revenue diversification and ESG compliance metrics?
What are the implications of cancelling the ₹750 million non-convertible debenture issuance for the company's future capital structure and debt financing strategies?
Given the significant rise in employee benefit expenses and finance costs alongside revenue growth, how sustainable are the current profit margins in the upcoming quarters?


































